Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07644858 · ClinicalTrials.gov registry record
MammoVerse: Breast Cancer Sexual Health Focus Groups
A clinical trial, sponsored by University of Central Florida.
- Completed
- Registry status
- 24
- Enrollment target
NCT07644858 is a clinical trial that has completed, run by University of Central Florida. The registered enrollment target is 24 participants.
The verdict
NCT07644858 has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the lived experiences, emotional challenges, and coping processes related to changes in sexual health and intimacy among women diagnosed with breast cancer. Insights gained from participants' personal experiences will provide a deeper understanding of patients' informational, emotional, and relational support needs, which will inform the development of an AI-driven digital support platform aimed at delivering personalized education, facilitating communication, and improving overall quality of life among women living with and beyond breast cancer in Florida. The study involves focus group discussions conducted via Zoom and online questionnaires administered to breast cancer patients and survivors.
Interventions
- OTHER Questionnaires and Focus Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-03-12 |
| Est. Completion | 2026-06-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07644858
The ClinicalTrials.gov registry entry for NCT07644858 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires and Focus Group is the first listed.
NCT07644858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07644858 about?
NCT07644858 is a clinical study titled "MammoVerse: Breast Cancer Sexual Health Focus Groups". The purpose of this study is to explore the lived experiences, emotional challenges, and coping processes related to changes in sexual health and intimacy among women diagnosed with breast cancer. Insights gained from participants' personal experiences will provide a deeper understanding of patients...
What is the current status of trial NCT07644858?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2026-03-12. Estimated completion is 2026-06-05.
What interventions are being tested in trial NCT07644858?
The interventions under investigation include: Questionnaires and Focus Group (OTHER).
Who is sponsoring clinical trial NCT07644858?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.